Demand Better For Patients, Survival At Purplestride, The Walk To End Pancreatic Cancer

PurpleStride Supports the Pancreatic Cancer Action Network’s Urgent Mission to Save Lives and Double Pancreatic Cancer Survival


PARSIPPANY — Thousands will walk to end pancreatic cancer, the world’s toughest cancer, at PurpleStride New Jersey on Sunday, November 10, marking the 10 Year Anniversary of the event. Since its inception in 2010, PurpleStride New Jersey has raised over $3 million with over 18,400 participants. The community event is hosted by the Pancreatic Cancer Action Network (PanCAN) New Jersey Affiliate.

PurpleStride New Jersey will take place at the Mack-Cali Business Campus at 1 Campus Drive in Parsippany. The event will be emceed by Dan Mannarino, PIX11 Morning News anchor and is supported by National Presenting Sponsor Celgene, National Gold Sponsor AbbVie, National Gold Sponsor and Flagship Team Ipsen Biopharmaceuticals, Inc., Gold Sponsor Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, Gold Sponsor Atlantic Health System Cancer Care, and Gold Media Sponsors WFAN FM 101.9/WFAN 660 AM, WCBS 880 AM and PIX11.

Kayla Zimmer, the Affiliate Chair for the New Jersey Affiliate, lost her mother, Brenda, to the disease at age 43.

“The only way to improve outcomes and extend lives is through research, which comes at a cost,” Zimmer said. “PurpleStride gives us the opportunity to raise the vital funds and awareness needed to tackle this disease and find a cure.”

Pancreatic cancer is the third leading cause of cancer-related death in the U.S. with a five-year survival rate of just 9 percent. In order to save lives and double pancreatic cancer survival, PanCAN urges the New Jersey community to join PurpleStride. Funds raised through the event support critical research, clinical initiatives and patient services, including Know Your Tumor®, Precision PromiseSMClinical Trial Finder and the Patient Registry.

To register, donate or learn more about PurpleStride New Jersey click here.